Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | HOME | SURVANTA® |
Description | Trust what time has Learn about SURVANTA® (beractant) dosing, administration, safety and efficacy for prevention and treatment of respiratory distress syndrome |
Keywords | RDS, RDS treatment/rescue, RDS prevention, surfactant, surfactant dosing, surfactant administration |
WebSite | survanta.com |
Host IP | 89.234.34.227 |
Location | United Kingdom |
Site | Rank |
US$4,358,502
Last updated: 2022-09-23 04:35:22
survanta.com has Semrush global rank of 2,428,427. survanta.com has an estimated worth of US$ 4,358,502, based on its estimated Ads revenue. survanta.com receives approximately 502,905 unique visitors each day. Its web server is located in United Kingdom, with IP address 89.234.34.227. According to SiteAdvisor, survanta.com is safe to visit. |
Purchase/Sale Value | US$4,358,502 |
Daily Ads Revenue | US$4,024 |
Monthly Ads Revenue | US$120,697 |
Yearly Ads Revenue | US$1,448,364 |
Daily Unique Visitors | 33,527 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
survanta.com. | A | 3600 | IP: 89.234.34.227 |
survanta.com. | NS | 3600 | NS Record: abvsgdmzns1.abbvie.com. |
survanta.com. | NS | 3600 | NS Record: abvludmzns1.abbvie.com. |
survanta.com. | NS | 3600 | NS Record: abvegdmzns1.abbvie.com. |
survanta.com. | TXT | 3600 | TXT Record: v=spf1 exists:%{i}._i.%{d}._d.espf.dmp.cisco.com include:%{d}.ff.spf-protect.dmp.cisco.com -all |
For Healthcare Professionals Important Safety Information Prescribing Information Contact Medical Information Edited for Security Audit - End--> HOME INDICATIONS LEGACY EFFICACY Dosage Dosing Procedure FAQs For Healthcare Professionals Menu ---> Trust what time has tested On the front line helping little fighters since 1991 1 INDICATION AND IMPORTANT SAFETY INFORMATION 2 INDICATION 2 SURVANTA ® (beractant) is indicated for prevention and treatment (“rescue”) of Respiratory Distress Syndrome (RDS) (hyaline membrane disease) in premature infants. IMPORTANT SAFETY INFORMATION Warnings: SURVANTA can rapidly affect oxygenation and lung compliance within minutes of administration of SURVANTA. Therefore, its use should be restricted to a highly supervised clinical setting with immediate availability of clinicians experienced with intubation, ventilator management, and general care of premature infants. Infants receiving SURVANTA should be frequently monitored with arterial or |
HTTP/1.1 301 Moved Permanently Content-Length: 144 Content-Type: text/html; charset=UTF-8 Location: https://survanta.com/ Server: Date: Tue, 04 Jan 2022 08:46:10 GMT HTTP/1.1 200 OK Cache-Control: private Content-Length: 23813 Content-Type: text/html; charset=utf-8 Server: X-AspNetMvc-Version: 5.0 X-AspNet-Version: 4.0.30319 Date: Tue, 04 Jan 2022 08:46:10 GMT |
Domain Name: SURVANTA.COM Registry Domain ID: 2492105_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-10-18T09:14:36Z Creation Date: 1998-11-20T05:00:00Z Registry Expiry Date: 2022-11-19T05:00:00Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: ABVEGDMZNS1.ABBVIE.COM Name Server: ABVLUDMZNS1.ABBVIE.COM Name Server: ABVSGDMZNS1.ABBVIE.COM DNSSEC: unsigned >>> Last update of whois database: 2022-01-04T07:45:28Z <<< |